ADIAL PHARMACEUTICALS, INC. - Common stock, par value $0.001 per share (ADIL)
Historical Holders from Q3 2023 to Q4 2025
-
Type / Class
-
Equity / Common stock, par value $0.001 per share
-
Symbol
-
ADIL on Nasdaq
-
Shares outstanding
-
15,938,643
-
Price per share
-
$0.22
-
All holders as of 30 Sep 2025
-
Q3 2025
-
Total 13F shares
-
608,083
-
Total reported value
-
$214,070
-
% of total 13F portfolios
-
0%
-
Share change
-
+373,378
-
Value change
-
+$133,627
-
Number of holders
-
16
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Significant Owners of ADIAL PHARMACEUTICALS, INC. - Common stock, par value $0.001 per share (ADIL) based on Schedule 13D/G filings
As of 30 Sep 2025,
ADIAL PHARMACEUTICALS, INC. - Common stock, par value $0.001 per share (ADIL) has
16
institutional shareholders
filing 13F forms.
They hold
608,083 shares.
of 15,938,643
outstanding shares (3.8%)
.
Institutional Holders of ADIAL PHARMACEUTICALS, INC. - Common stock, par value $0.001 per share (ADIL) across Reporting Periods
| Period |
Reported Shares, Excl. Options
|
Value, Excl. Options
|
Value Change
|
Puts Notional Value
|
Calls Notional Value
|
Price
|
Investors
|
|
2025 Q4
|
27
|
$6
|
|
|
|
$0.22
|
1
|
|
2025 Q3
|
608,083
|
$214,070
|
+$133,627
|
|
|
$0.35
|
16
|
|
2025 Q2
|
234,705
|
$70,153
|
-$9,760
|
|
|
$0.30
|
16
|
|
2025 Q1
|
234,640
|
$149,046
|
-$82,917
|
|
|
$0.63
|
12
|
|
2024 Q4
|
289,676
|
$292,303
|
+$95,706
|
|
|
$1.01
|
13
|
|
2024 Q3
|
194,053
|
$193,859
|
-$98,515
|
|
|
$1.00
|
11
|
|
2024 Q2
|
283,661
|
$325,599
|
+$119,966
|
|
|
$1.15
|
13
|
|
2024 Q1
|
176,048
|
$233,389
|
-$211,877
|
|
|
$1.33
|
13
|
|
2023 Q4
|
264,302
|
$491,452
|
+$385,501
|
|
|
$1.86
|
14
|
|
2023 Q3
|
56,961
|
$158,346
|
+$158,346
|
|
|
$2.78
|
8
|